CAREMARK RX 4Q EARNINGS RISE TO $290.7M
Pharmacy benefits manager Caremark Rx Inc. on Wednesday said profit rose more
than 40 percent in the fourth quarter, driven by its prescriptions by mail business.
Earnings rose to $290.7 million, or 64 cents per share, in the three months
ended Dec. 31 from $205.1 million, or 45 cents per share, in the year-ago period.
Excluding integration expenses and a one-time gain on the sale of stake in a
subsidiary, earnings were 55 cents per share.